Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Amylase Market by Source (Microbes, Plants, Animals) , by Type (Alpha-amylase, Beta-amylase, Gamma-amylase) by End-use (Food and beverage, Textile, Paper and pulp, Pharmaceutical, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A15505

Pages: 250

Charts: 61

Tables: 226

Amylase Market Research, 2033

The global amylase market was valued at $2.7 billion in 2023, and is projected to reach $4.4 Billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

 

Market Introduction and Definition

Amylases are a group of enzymes that catalyze the hydrolysis of starch into sugars. They are crucial in various biological processes and industrial applications. Amylases have potential use in a wide range of industrial activities, including food, fermentation, and pharmaceuticals. Amylases can be obtained from plants, animals, or microorganisms. Nonetheless, fungal and bacterial amylases have dominated industrial uses. Amylase is required for the conversion of starches to oligosaccharides. Starch is an essential component of the human diet and a storage product in many commercially significant crops, including wheat, rice, maize, tapioca, and potato.

Moreover, amylases are among the most often used enzymes in business. These enzymes hydrolyze starch molecules, converting them into glucose-based polymers. Amylases have the potential to be used in a variety of commercial activities, including food production, fermentation, and pharmaceuticals. The enzyme ɑ-amylase is widely used in brewing starch-based beverages such as liquor and beer. It is done by fermentation, in which yeast consumes sugar and produces alcohol. In breadmaking, yeasts, which already produce amylase, degrade the starch in the flour into carbon dioxide and ethanol, giving rise to the bread while also contributing taste. In molecular biology, amylase can be used to select antibiotic-resistant genes.

Key Takeaways

  • Over 1,500 product literatures, industry releases, annual reports, and various documents from major amylase industry participants, along with credible industry journals, trade association releases, and government websites, have been reviewed to generate valuable industry insights.
  • The amylase market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($million)   and volume (kilotons) for the projected period 2024-2033.
  • The study integrated high-quality data, expert opinions and analysis, and crucial independent perspectives. This research approach aims to provide a balanced view of global markets, assisting stakeholders in making informed decisions to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Source
    • Microbes
    • Plants
    • Animals
  • By Type
    • Alpha-amylase
    • Beta-amylase
    • Gamma-amylase
  • By End-use
    • Food and beverage
    • Textile
    • Paper and pulp
    • Pharmaceutical
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Kerry Group
  • International Flavors & Fragrances Inc.
  • Infinita Biotech Private Limited
  • Sisco Research Laboratories Pvt Ltd
  • Antozyme Biotech Private Limited
  • AB Enzymes
  • Biolaxi Corporation
  • DSM
  • Chemzyme Biotechnology Co., Ltd
  • Novozymes A/S

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: AMYLASE MARKET, BY SOURCE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Source

    • 4.2. Microbes

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Plants

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Animals

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: AMYLASE MARKET, BY TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Type

    • 5.2. Alpha-amylase

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Beta-amylase

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Gamma-amylase

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: AMYLASE MARKET, BY END-USE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End-use

    • 6.2. Food And Beverage

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Textile

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Paper And Pulp

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Pharmaceutical

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Others

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: AMYLASE MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Source

      • 7.2.3. Market Size and Forecast, By Type

      • 7.2.4. Market Size and Forecast, By End-use

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Amylase Market

        • 7.2.6.1. Market Size and Forecast, By Source
        • 7.2.6.2. Market Size and Forecast, By Type
        • 7.2.6.3. Market Size and Forecast, By End-use

      • 7.2.7. Canada Amylase Market

        • 7.2.7.1. Market Size and Forecast, By Source
        • 7.2.7.2. Market Size and Forecast, By Type
        • 7.2.7.3. Market Size and Forecast, By End-use

      • 7.2.8. Mexico Amylase Market

        • 7.2.8.1. Market Size and Forecast, By Source
        • 7.2.8.2. Market Size and Forecast, By Type
        • 7.2.8.3. Market Size and Forecast, By End-use

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Source

      • 7.3.3. Market Size and Forecast, By Type

      • 7.3.4. Market Size and Forecast, By End-use

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Amylase Market

        • 7.3.6.1. Market Size and Forecast, By Source
        • 7.3.6.2. Market Size and Forecast, By Type
        • 7.3.6.3. Market Size and Forecast, By End-use

      • 7.3.7. Germany Amylase Market

        • 7.3.7.1. Market Size and Forecast, By Source
        • 7.3.7.2. Market Size and Forecast, By Type
        • 7.3.7.3. Market Size and Forecast, By End-use

      • 7.3.8. Italy Amylase Market

        • 7.3.8.1. Market Size and Forecast, By Source
        • 7.3.8.2. Market Size and Forecast, By Type
        • 7.3.8.3. Market Size and Forecast, By End-use

      • 7.3.9. Spain Amylase Market

        • 7.3.9.1. Market Size and Forecast, By Source
        • 7.3.9.2. Market Size and Forecast, By Type
        • 7.3.9.3. Market Size and Forecast, By End-use

      • 7.3.10. UK Amylase Market

        • 7.3.10.1. Market Size and Forecast, By Source
        • 7.3.10.2. Market Size and Forecast, By Type
        • 7.3.10.3. Market Size and Forecast, By End-use

      • 7.3.11. Russia Amylase Market

        • 7.3.11.1. Market Size and Forecast, By Source
        • 7.3.11.2. Market Size and Forecast, By Type
        • 7.3.11.3. Market Size and Forecast, By End-use

      • 7.3.12. Rest Of Europe Amylase Market

        • 7.3.12.1. Market Size and Forecast, By Source
        • 7.3.12.2. Market Size and Forecast, By Type
        • 7.3.12.3. Market Size and Forecast, By End-use

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Source

      • 7.4.3. Market Size and Forecast, By Type

      • 7.4.4. Market Size and Forecast, By End-use

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Amylase Market

        • 7.4.6.1. Market Size and Forecast, By Source
        • 7.4.6.2. Market Size and Forecast, By Type
        • 7.4.6.3. Market Size and Forecast, By End-use

      • 7.4.7. Japan Amylase Market

        • 7.4.7.1. Market Size and Forecast, By Source
        • 7.4.7.2. Market Size and Forecast, By Type
        • 7.4.7.3. Market Size and Forecast, By End-use

      • 7.4.8. India Amylase Market

        • 7.4.8.1. Market Size and Forecast, By Source
        • 7.4.8.2. Market Size and Forecast, By Type
        • 7.4.8.3. Market Size and Forecast, By End-use

      • 7.4.9. South Korea Amylase Market

        • 7.4.9.1. Market Size and Forecast, By Source
        • 7.4.9.2. Market Size and Forecast, By Type
        • 7.4.9.3. Market Size and Forecast, By End-use

      • 7.4.10. Australia Amylase Market

        • 7.4.10.1. Market Size and Forecast, By Source
        • 7.4.10.2. Market Size and Forecast, By Type
        • 7.4.10.3. Market Size and Forecast, By End-use

      • 7.4.11. Thailand Amylase Market

        • 7.4.11.1. Market Size and Forecast, By Source
        • 7.4.11.2. Market Size and Forecast, By Type
        • 7.4.11.3. Market Size and Forecast, By End-use

      • 7.4.12. Malaysia Amylase Market

        • 7.4.12.1. Market Size and Forecast, By Source
        • 7.4.12.2. Market Size and Forecast, By Type
        • 7.4.12.3. Market Size and Forecast, By End-use

      • 7.4.13. Indonesia Amylase Market

        • 7.4.13.1. Market Size and Forecast, By Source
        • 7.4.13.2. Market Size and Forecast, By Type
        • 7.4.13.3. Market Size and Forecast, By End-use

      • 7.4.14. Rest of Asia Pacific Amylase Market

        • 7.4.14.1. Market Size and Forecast, By Source
        • 7.4.14.2. Market Size and Forecast, By Type
        • 7.4.14.3. Market Size and Forecast, By End-use

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Source

      • 7.5.3. Market Size and Forecast, By Type

      • 7.5.4. Market Size and Forecast, By End-use

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Amylase Market

        • 7.5.6.1. Market Size and Forecast, By Source
        • 7.5.6.2. Market Size and Forecast, By Type
        • 7.5.6.3. Market Size and Forecast, By End-use

      • 7.5.7. South Africa Amylase Market

        • 7.5.7.1. Market Size and Forecast, By Source
        • 7.5.7.2. Market Size and Forecast, By Type
        • 7.5.7.3. Market Size and Forecast, By End-use

      • 7.5.8. Saudi Arabia Amylase Market

        • 7.5.8.1. Market Size and Forecast, By Source
        • 7.5.8.2. Market Size and Forecast, By Type
        • 7.5.8.3. Market Size and Forecast, By End-use

      • 7.5.9. UAE Amylase Market

        • 7.5.9.1. Market Size and Forecast, By Source
        • 7.5.9.2. Market Size and Forecast, By Type
        • 7.5.9.3. Market Size and Forecast, By End-use

      • 7.5.10. Argentina Amylase Market

        • 7.5.10.1. Market Size and Forecast, By Source
        • 7.5.10.2. Market Size and Forecast, By Type
        • 7.5.10.3. Market Size and Forecast, By End-use

      • 7.5.11. Rest of LAMEA Amylase Market

        • 7.5.11.1. Market Size and Forecast, By Source
        • 7.5.11.2. Market Size and Forecast, By Type
        • 7.5.11.3. Market Size and Forecast, By End-use

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Novozymes A/S

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. DSM

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. AB Enzymes

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Chemzyme Biotechnology Co., Ltd

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Sisco Research Laboratories Pvt Ltd

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Kerry Group

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Biolaxi Corporation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. International Flavors And Fragrances Inc.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Infinita Biotech Private Limited

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Antozyme Biotech Private Limited

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL AMYLASE MARKET, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL AMYLASE MARKET FOR MICROBES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL AMYLASE MARKET FOR PLANTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL AMYLASE MARKET FOR ANIMALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL AMYLASE MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL AMYLASE MARKET FOR ALPHA-AMYLASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL AMYLASE MARKET FOR BETA-AMYLASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL AMYLASE MARKET FOR GAMMA-AMYLASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL AMYLASE MARKET, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL AMYLASE MARKET FOR FOOD AND BEVERAGE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL AMYLASE MARKET FOR TEXTILE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL AMYLASE MARKET FOR PAPER AND PULP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL AMYLASE MARKET FOR PHARMACEUTICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL AMYLASE MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL AMYLASE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA AMYLASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 20. U.S. AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. U.S. AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 23. CANADA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 24. CANADA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. CANADA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE AMYLASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 39. ITALY AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 40. ITALY AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. ITALY AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 45. UK AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 46. UK AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. UK AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC AMYLASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 58. CHINA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 59. CHINA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. CHINA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 64. INDIA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 65. INDIA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. INDIA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA AMYLASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 98. UAE AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 99. UAE AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 100. UAE AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA AMYLASE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA AMYLASE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA AMYLASE, BY END-USE, 2025-2033 ($MILLION)
  • TABLE 107. NOVOZYMES A/S: KEY EXECUTIVES
  • TABLE 108. NOVOZYMES A/S: COMPANY SNAPSHOT
  • TABLE 109. NOVOZYMES A/S: OPERATING SEGMENTS
  • TABLE 110. NOVOZYMES A/S: PRODUCT PORTFOLIO
  • TABLE 111. NOVOZYMES A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. DSM: KEY EXECUTIVES
  • TABLE 113. DSM: COMPANY SNAPSHOT
  • TABLE 114. DSM: OPERATING SEGMENTS
  • TABLE 115. DSM: PRODUCT PORTFOLIO
  • TABLE 116. DSM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. AB ENZYMES: KEY EXECUTIVES
  • TABLE 118. AB ENZYMES: COMPANY SNAPSHOT
  • TABLE 119. AB ENZYMES: OPERATING SEGMENTS
  • TABLE 120. AB ENZYMES: PRODUCT PORTFOLIO
  • TABLE 121. AB ENZYMES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. CHEMZYME BIOTECHNOLOGY CO., LTD: KEY EXECUTIVES
  • TABLE 123. CHEMZYME BIOTECHNOLOGY CO., LTD: COMPANY SNAPSHOT
  • TABLE 124. CHEMZYME BIOTECHNOLOGY CO., LTD: OPERATING SEGMENTS
  • TABLE 125. CHEMZYME BIOTECHNOLOGY CO., LTD: PRODUCT PORTFOLIO
  • TABLE 126. CHEMZYME BIOTECHNOLOGY CO., LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. SISCO RESEARCH LABORATORIES PVT LTD: KEY EXECUTIVES
  • TABLE 128. SISCO RESEARCH LABORATORIES PVT LTD: COMPANY SNAPSHOT
  • TABLE 129. SISCO RESEARCH LABORATORIES PVT LTD: OPERATING SEGMENTS
  • TABLE 130. SISCO RESEARCH LABORATORIES PVT LTD: PRODUCT PORTFOLIO
  • TABLE 131. SISCO RESEARCH LABORATORIES PVT LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. KERRY GROUP: KEY EXECUTIVES
  • TABLE 133. KERRY GROUP: COMPANY SNAPSHOT
  • TABLE 134. KERRY GROUP: OPERATING SEGMENTS
  • TABLE 135. KERRY GROUP: PRODUCT PORTFOLIO
  • TABLE 136. KERRY GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. BIOLAXI CORPORATION: KEY EXECUTIVES
  • TABLE 138. BIOLAXI CORPORATION: COMPANY SNAPSHOT
  • TABLE 139. BIOLAXI CORPORATION: OPERATING SEGMENTS
  • TABLE 140. BIOLAXI CORPORATION: PRODUCT PORTFOLIO
  • TABLE 141. BIOLAXI CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: KEY EXECUTIVES
  • TABLE 143. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: COMPANY SNAPSHOT
  • TABLE 144. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: OPERATING SEGMENTS
  • TABLE 145. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: PRODUCT PORTFOLIO
  • TABLE 146. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. INFINITA BIOTECH PRIVATE LIMITED: KEY EXECUTIVES
  • TABLE 148. INFINITA BIOTECH PRIVATE LIMITED: COMPANY SNAPSHOT
  • TABLE 149. INFINITA BIOTECH PRIVATE LIMITED: OPERATING SEGMENTS
  • TABLE 150. INFINITA BIOTECH PRIVATE LIMITED: PRODUCT PORTFOLIO
  • TABLE 151. INFINITA BIOTECH PRIVATE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. ANTOZYME BIOTECH PRIVATE LIMITED: KEY EXECUTIVES
  • TABLE 153. ANTOZYME BIOTECH PRIVATE LIMITED: COMPANY SNAPSHOT
  • TABLE 154. ANTOZYME BIOTECH PRIVATE LIMITED: OPERATING SEGMENTS
  • TABLE 155. ANTOZYME BIOTECH PRIVATE LIMITED: PRODUCT PORTFOLIO
  • TABLE 156. ANTOZYME BIOTECH PRIVATE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL AMYLASE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL AMYLASE MARKET
  • FIGURE 3. SEGMENTATION AMYLASE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN AMYLASE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALAMYLASE MARKET
  • FIGURE 11. AMYLASE MARKET SEGMENTATION, BY BY SOURCE
  • FIGURE 12. AMYLASE MARKET FOR MICROBES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. AMYLASE MARKET FOR PLANTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. AMYLASE MARKET FOR ANIMALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. AMYLASE MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 16. AMYLASE MARKET FOR ALPHA-AMYLASE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. AMYLASE MARKET FOR BETA-AMYLASE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. AMYLASE MARKET FOR GAMMA-AMYLASE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. AMYLASE MARKET SEGMENTATION, BY BY END-USE
  • FIGURE 20. AMYLASE MARKET FOR FOOD AND BEVERAGE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. AMYLASE MARKET FOR TEXTILE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. AMYLASE MARKET FOR PAPER AND PULP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. AMYLASE MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. AMYLASE MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: AMYLASE MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. NOVOZYMES A/S: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. NOVOZYMES A/S: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. NOVOZYMES A/S: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. DSM: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. DSM: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. DSM: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. AB ENZYMES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. AB ENZYMES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. AB ENZYMES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. CHEMZYME BIOTECHNOLOGY CO., LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. CHEMZYME BIOTECHNOLOGY CO., LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. CHEMZYME BIOTECHNOLOGY CO., LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. SISCO RESEARCH LABORATORIES PVT LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. SISCO RESEARCH LABORATORIES PVT LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. SISCO RESEARCH LABORATORIES PVT LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. KERRY GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. KERRY GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. KERRY GROUP: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. BIOLAXI CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. BIOLAXI CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. BIOLAXI CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. INFINITA BIOTECH PRIVATE LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. INFINITA BIOTECH PRIVATE LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. INFINITA BIOTECH PRIVATE LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. ANTOZYME BIOTECH PRIVATE LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. ANTOZYME BIOTECH PRIVATE LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. ANTOZYME BIOTECH PRIVATE LIMITED: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Amylase Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved